Option chain shows key data for A SPAC III Acquisition Corp. - Right's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for A SPAC III Acquisition Corp. - Right.

A SPAC III Acquisition Corp. - Right (NASDAQ:ASPCR) Stock, Option Chain

A SPAC III Acquisition Corp. - Right

Lucid Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NYSE">LCID</a>) short percent of float has risen 6.99% since its last report. The company recently reported that it has 271.05 million shares sold short, which is 16.53% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.6 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Lucid Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740758430_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Lucid Group has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Lucid Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Lucid Group's peer group average for short interest as a percentage of float is 8.89%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

LCID

Looking Into Lucid Group's Recent Short Interest

Citizens Capital Markets analyst Constantine Davides maintains Privia Health Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRVA#NASDAQ">PRVA</a>) with a Market Outperform and raises the price target from $26 to $29.

News

Price Target

Analyst Ratings

PRVA

Citizens Capital Markets Maintains Market Outperform on Privia Health Gr, Raises Price Target to $29

Options

Markets

Iamgold Option Alert: Jun 20 $6 Calls Sweep (5) Near The Ask: 3500 @ $0.518 vs 1609 OI; Ref=$5.4699

Citizens Capital Markets analyst Mitch Germain maintains Plymouth Industrial REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLYM#NYSE">PLYM</a>) with a Market Outperform and lowers the price target from $27 to $24.

PLYM

Citizens Capital Markets Maintains Market Outperform on Plymouth Industrial REIT, Lowers Price Target to $24

CLSK

CleanSpark Option Alert: Apr 17 $15 Calls At The Ask: 5000 @ $0.15 vs 880 OI; Ref=$8.0514

Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRVA#NASDAQ">PRVA</a>) with a Buy and raises the price target from $29 to $30.

Canaccord Genuity Maintains Buy on Privia Health Gr, Raises Price Target to $30

Citizens Capital Markets analyst Matthew Carletti maintains BeOne Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONC#NASDAQ">ONC</a>) with a Market Outperform and raises the price target from $288 to $348.

Citizens Capital Markets Maintains Market Outperform on BeOne Medicines, Raises Price Target to $348

Polestar Automotive Holding Uk Plc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNY#NASDAQ">PSNY</a>) has <a href="https://www.benzinga.com/pressreleases/25/02/b44038615/polestar-secures-usd-450-million-term-facility-and-renews-eur-480-million-green-trade-finance-faci">obtained further financial backing</a>, underscoring its focus on growth and long-term sustainability. 
The company has finalized a 12-month term facility of up to $450 million and renewed its 480 million Euros ($499.60 million) Green Trade Finance Facility (TFF). 
This comes after securing more than $800 million in term facilities in December 2024, enhancing its financial position even further.
Polestar also plans to announce global retail sales volumes for first-quarter 2025 on April 10, 2025. 
The company intends to release its full-year and fourth-quarter results for 2024 ahead of or simultaneously with its Annual Report filing on Form 20-F in April 2025.
Also Read: <a href="https://www.benzinga.com/markets/equities/25/02/44041348/werides-robobus-rolls-out-in-france-with-renault-beti-backing-details">WeRide&#8217;s Robobus Rolls Out In France With Renault &amp; Beti Backing: Details</a>
The company had originally planned to release its postponed fourth-quarter results in March, reported Reuters.
For the third-quarter, Polestar saw a <a href="https://www.benzinga.com/25/01/43032533/polestar-stock-skids-after-weak-q3-revenue-but-ceo-projects-2025-to-be-the-strongest-year-ever">10% year-over-year decrease in revenue</a>, dropping to $550.7 million, primarily due to reduced volume and market conditions. Retail sales totaled 12,548 vehicles, marking an 8% decline compared to the previous year.
It also reported a net loss of $323 million, while its adjusted EBITDA loss improved by 28%, reaching $180 million, thanks to cost-cutting measures.
The company said lower-than-expected Polestar 3 and 4 sales, inventory adjustments and market discounting impacted fourth-quarter performance.
In order to attract Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) customers who have harbored <a href="https://www.benzinga.com/tech/25/02/43933726/polestar-attempts-to-woo-disgruntled-tesla-owners-with-offers-2025-to-be-strongest-year-in-polestars-history">negative sentiments about Musk&#8217;s involvement</a> in politics, Polestar is providing up to $20,000 to Tesla vehicle owners who decide to switch and lease a Polestar 3. 
Price Action: PSNY shares are trading lower by 3.15% at $1.08 at last check Friday.
Read Next: <a href="https://www.benzinga.com/markets/equities/25/02/44018649/spacex-rocket-launches-intuitive-machines-athena-lander-details">SpaceX Rocket Launches Intuitive Machines&#8217; Athena Lander: Details</a>
Photo: Shutterstock

General

PSNY

TSLA

Polestar Secures New $450M Financing Deal To Boost Growth

WIIM

ADGM

Adagio Medical shares are trading lower after the company announced a reduction in workforce in a strategic restructuring.

Canaccord Genuity analyst Richard Close maintains Progyny (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGNY#NASDAQ">PGNY</a>) with a Hold and raises the price target from $17 to $23.

PGNY

Canaccord Genuity Maintains Hold on Progyny, Raises Price Target to $23

Citizens Capital Markets analyst Daniel Stauder maintains LeMaitre Vascular (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMAT#NASDAQ">LMAT</a>) with a Buy and raises the price target from $105 to $110.

LMAT

Citizens Capital Markets Maintains Buy on LeMaitre Vascular, Raises Price Target to $110

RMNI

Rimini Street shares are trading higher after the company reported better-than-expected Q4 financial results.

Citizens Capital Markets analyst Joey Marincek maintains Jamf Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAMF#NASDAQ">JAMF</a>) with a Market Outperform and lowers the price target from $30 to $27.

JAMF

Citizens Capital Markets Maintains Market Outperform on Jamf Holding, Lowers Price Target to $27

Canaccord Genuity analyst Kyle Mikson maintains Natera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>) with a Buy and raises the price target from $180 to $195.

NTRA

Canaccord Genuity Maintains Buy on Natera, Raises Price Target to $195

Canaccord Genuity analyst David Hynes maintains Jamf Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAMF#NASDAQ">JAMF</a>) with a Buy and lowers the price target from $21 to $19.

Canaccord Genuity Maintains Buy on Jamf Holding, Lowers Price Target to $19

Citizens Capital Markets analyst Matthew Carletti maintains Hamilton Insurance Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HG#NYSE">HG</a>) with a Market Outperform and raises the price target from $25 to $27.

Citizens Capital Markets Maintains Market Outperform on Hamilton Insurance Group, Raises Price Target to $27

PBYI

Puma Biotechnology shares are trading higher after the company reported better-than-expected Q4 financial results.

Citizens Capital Markets analyst Matthew Carletti maintains HCI Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCI#NYSE">HCI</a>) with a Market Outperform and raises the price target from $150 to $165.

Citizens Capital Markets Maintains Market Outperform on HCI Group, Raises Price Target to $165

Citigroup Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) wrongly credited <a target="_blank" href="https://www.benzinga.com/topic/citigroup" rel="noreferrer noopener">a client&#8217;s account</a> with $81 trillion instead of remitting only $280.
Two officials failed to detect the wrong internal transfer last April, though a third employee detected the problem 90 minutes after the erroneous posting.
Citigroup reversed the payment several hours later, the Financial Times <a target="_blank" href="https://www.ft.com/content/9921925e-5a32-48cc-a3e3-3f77042477d2" rel="noreferrer noopener">cited</a> unnamed sources familiar with the matter.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/02/44042301/fubotv-projects-subscriber-fall-in-q1-after-q4-topline-growth-stock-tumbles" rel="noreferrer noopener">FuboTV Projects Subscriber Fall In Q1 After Q4 Topline Growth, Stock Tumbles</a>
Citigroup did not face any loss of funds due to the error as per the Financial Times report and the bank promptly disclosed the matter to the Federal Reserve and Office of the Comptroller of the Currency.
A total of 10 near misses of $1 billion or more occurred at Citigroup in 2024, down from 13 in 2023, according to the Financial Times report.
The errors at Citigroup highlighted how the Wall Street bank grappled with operational glitches nearly five years after it mistakenly remitted $900 million to creditors engaged in a contentious battle over the debt of cosmetics group Revlon that led to the firing of then-CEO Michael Corbat, massive penalties and regulatory consent orders.
Citigroup had to pay a <a target="_blank" href="https://www.benzinga.com/news/24/07/39735239/fed-penalizes-citigroup-136m-for-data-management-failures" rel="noreferrer noopener">penalty of $136 million</a> in 2024 to the Office of the Comptroller of the Currency (OCC) and the Federal Reserve for inadequate data management progress despite CEO Jane Fraser prioritizing Citigroup&#8217;s regulatory issues.
In 2020, the Federal Reserve <a target="_blank" href="https://www.benzinga.com/markets/equities/24/08/40218034/appeals-court-rejects-citigroup-whistleblowers-bid-for-share-in-400m-fine-report" rel="noreferrer noopener">slapped a penalty</a> of $400 million on&nbsp;Citigroup due to its longstanding deficiencies.
Recently, Warren Buffett&#8217;s Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) sold 74% of its <a href="https://www.benzinga.com/news/25/02/43912215/berkshire-hathaway-dumps-ulta-beauty-citi-and-etfs-but-buffett-just-bet-1-2-billion-on-this-alcohol-giant" target="_blank" rel="noreferrer noopener">stake in Citigroup</a>.
Truist and Goldman Sachs, Keefe, Bruyette &amp; Woods expressed their optimism about Citigroup after its fourth-quarter results, citing its franchise and recent management changes. <a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/43038644/citi-cheap-valuation-investment-banking-and-trading-outlook-paired-with-accelerating-buybacks-sparks-optimism-analyst" target="_blank" rel="noreferrer noopener">Buybacks are expected to accelerate</a> with a potential further acceleration should Basel III Endgame be meaningfully watered down.
C Price Action: Citigroup stock is down 0.32% at $78.62 at publication Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/markets/emerging-markets/25/02/44040537/tiktok-invests-8-8-billion-in-thailand-data-centers-bypassing-us-china-tech-tensions" target="_blank" rel="noreferrer noopener">TikTok Invests $8.8 Billion in Thailand Data Centers, Bypassing US-China Tech Tensions</a></li>
</ul>
Photo: Shutterstock

Citigroup Accidentally Sends $81 Trillion To Client, Reverses Error Within Hours

Canaccord Genuity analyst Kingsley Crane maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Buy and raises the price target from $130 to $135.

Comments

A SPAC III Acquisition Corp. - Right

A SPAC III Acquisition Corp. - Right (ASPCR) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga